v3.26.3
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non-Controlling Interest (“NCI”)
Beginning balance (in shares) at Dec. 31, 2024   153,206        
Beginning balance at Dec. 31, 2024 $ 126,256 $ 15 $ 512,022 $ (383,822) $ (1,896) $ (63)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   59        
Exercise of stock options 47   47      
Stock-based compensation 27,258   27,258      
Vesting of restricted stock units (“RSUs”) (in shares)   7,228        
Vesting of restricted stock units (“RSUs”) 1 $ 1        
Shares issued under the at-the-market (“ATM”) program, net of issuance costs/ Shares issued per equity purchase agreement (in shares)   6,152        
Shares issued under the at-the-market (“ATM”) program, net of issuance costs/ Shares issued per equity purchase agreement 8,705 $ 1 8,704      
Issuance of warrants 1,153   1,153      
Short-swing profit recovery 24   24      
Net loss (82,925)     (82,880)   (45)
Actuarial gain (loss) on pension 121       121  
Foreign currency translation (loss) gain (91)       (91)  
Reallocation of NCI due to forfeiture 0   (79)     79
Ending balance (in shares) at Sep. 30, 2025   166,645        
Ending balance at Sep. 30, 2025 80,549 $ 17 549,129 (466,702) (1,866) (29)
Beginning balance (in shares) at Jun. 30, 2025   160,689        
Beginning balance at Jun. 30, 2025 90,299 $ 16 532,095 (439,885) (1,900) (27)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   56        
Exercise of stock options 45   45      
Stock-based compensation 8,998   8,998      
Vesting of restricted stock units (“RSUs”) (in shares)   2,050        
Vesting of restricted stock units (“RSUs”) 0          
Shares issued under the at-the-market (“ATM”) program, net of issuance costs/ Shares issued per equity purchase agreement (in shares)   3,850        
Shares issued under the at-the-market (“ATM”) program, net of issuance costs/ Shares issued per equity purchase agreement 6,839 $ 1 6,838      
Issuance of warrants 1,153   1,153      
Net loss (26,819)     (26,817)   (2)
Actuarial gain (loss) on pension (114)       (114)  
Foreign currency translation (loss) gain 148       148  
Ending balance (in shares) at Sep. 30, 2025   166,645        
Ending balance at Sep. 30, 2025 $ 80,549 $ 17 549,129 (466,702) (1,866) (29)
Beginning balance (in shares) at Dec. 31, 2025 168,969 168,969        
Beginning balance at Dec. 31, 2025 $ 67,460 $ 17 555,873 (487,433) (966) (31)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 783 783        
Exercise of stock options $ 1,341   1,341      
Exercise of warrants (in shares)   855        
Exercise of warrants 1 $ 1        
Stock-based compensation 17,013   17,013      
Vesting of restricted stock units (“RSUs”) (in shares)   7,168        
Vesting of restricted stock units (“RSUs”) (4,450)   (4,450)      
Shares issued per Convertible Debentures (in shares)   4,090        
Shares issued per Convertible Debentures 17,546   17,546      
Shares issued under the at-the-market (“ATM”) program, net of issuance costs/ Shares issued per equity purchase agreement (in shares)   721        
Shares issued under the at-the-market (“ATM”) program, net of issuance costs/ Shares issued per equity purchase agreement 3,769   3,769      
Shares issued for acquisition of Development Vault, LLC (in shares)   500        
Shares issued for acquisition of Development Vault, LLC 2,245   2,245      
Purchase of capped calls (20,460)   (20,460)      
Paid-in-kind (“PIK”) distributions to redeemable non-controlling interest (“Redeemable NCI”) (3,326)   (3,326)      
Accretion of Redeemable NCI (3,959)   (3,959)      
Net loss (90,339)     (90,339)    
Actuarial gain (loss) on pension 260       260  
Foreign currency translation (loss) gain $ 498       498  
Ending balance (in shares) at Sep. 30, 2026 183,086 183,086        
Ending balance at Sep. 30, 2026 $ (12,401) $ 18 565,592 (577,772) (208) (31)
Beginning balance (in shares) at Jun. 30, 2026   179,940        
Beginning balance at Jun. 30, 2026 6,857 $ 18 557,315 (549,610) (835) (31)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   215        
Exercise of stock options 365   365      
Stock-based compensation 5,594   5,594      
Vesting of restricted stock units (“RSUs”) (in shares)   1,327        
Vesting of restricted stock units (“RSUs”) (1,029)   (1,029)      
Shares issued per Convertible Debentures (in shares)   1,104        
Shares issued per Convertible Debentures 3,792   3,792      
Shares issued for acquisition of Development Vault, LLC (in shares)   500        
Shares issued for acquisition of Development Vault, LLC 2,245   2,245      
Paid-in-kind (“PIK”) distributions to redeemable non-controlling interest (“Redeemable NCI”) (1,154)   (1,154)      
Accretion of Redeemable NCI (1,536)   (1,536)      
Net loss (28,162)     (28,162)    
Actuarial gain (loss) on pension 314       314  
Foreign currency translation (loss) gain $ 313       313  
Ending balance (in shares) at Sep. 30, 2026 183,086 183,086        
Ending balance at Sep. 30, 2026 $ (12,401) $ 18 $ 565,592 $ (577,772) $ (208) $ (31)